Ana SayfaBCRX • NASDAQ
add
BioCryst Pharmaceuticals Inc
$6,67
Borsa Açılış Saatinden Önce:(%0,15)+0,0100
$6,68
Kapalı: 21 Oca, 08:21:26 GMT-5 · USD · NASDAQ · Sorumluluk Reddi Beyanı
Önceki kapanış
$6,67
Yıllık aralık
$6,00 - $11,31
Piyasa değeri
1,41 Mr USD
Ort. Hacim
4,18 Mn
F/K oranı
-
Temettü getirisi
-
Birincil borsa
NASDAQ
Haberlerde
Hakkında
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China. Wikipedia
Kuruluş
1986
İnternet sitesi
Çalışanlar
580
